Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03018197 · ClinicalTrials.gov registry record · NA
Use of Electronic Personal Health Records to Improve Medication Adherence
A NA study, sponsored by Parkview Health.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT03018197 is a NA study that has completed, run by Parkview Health. The registered enrollment target is 90 participants.
The verdict
NCT03018197, a NA study, has completed, sponsored by Parkview Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to examine the use of a personal health record to improve medication adherence among patients with non-valvular atrial fibrillation taking dabigatran for primary prevention of embolic stroke.
Interventions
- OTHER Medication Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03018197
The ClinicalTrials.gov registry entry for NCT03018197 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Parkview Health, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medication Education is the first listed.
NCT03018197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03018197 about?
NCT03018197 is a clinical study titled "Use of Electronic Personal Health Records to Improve Medication Adherence". The purpose of this pilot study is to examine the use of a personal health record to improve medication adherence among patients with non-valvular atrial fibrillation taking dabigatran for primary prevention of embolic stroke.
What is the current status of trial NCT03018197?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2014-02. Estimated completion is 2014-07.
What interventions are being tested in trial NCT03018197?
The interventions under investigation include: Medication Education (OTHER).
Who is sponsoring clinical trial NCT03018197?
This trial is sponsored by Parkview Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.